Danaher

Belkins
Danaher is a global science and technology innovator committed to helping our customers solve complex challenges and improve quality of life around the world. A global network of more than 20 operating companies, we drive meaningful innovation in some of today’s most dynamic industries through our operating companies in five strategic platforms: Life Sciences, Diagnostics, Dental, Water Quality and Product Identification.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

3 WAYS PAYERS DRIVE POPULATION HEALTH MANAGEMENT IN CANCER CARE

HealthPayerIntelligence | February 07, 2020

news image

The industry’s transition into value-based care is characterized by a focus on data and patient centered care. By driving strong population health management, payers can excel in this value-based care model that relies on quality measures and patient outcomes to define successful care. Driving population health management is most needed but also particularly challenging for populations with complex, chronic diseases such as cancer. Cancer presents a population health challenge due to its m...

Read More

ONC ADDRESSES HEALTH IT INFRASTRUCTURE CHALLENGES IN NEW AGENDA

HITInfrastructure | February 27, 2020

news image

Innovative research and scientific breakthroughs may remain stagnant due to difficulties with health IT infrastructure and the lack of quality data, but ONC articulates ways to address these challenges in its new policy and development agenda. A new blog post written by the National Coordinator Don Rucker, MD, and ONC staffers Teresa Zayas Caban, Kevin Chaney, MGS, highlighted the efforts ONC is making to advance the nation’s health IT infrastructure to specifically achieve two goals...

Read More

AI DRUG DISCOVERY PLATFORM IDS POTENTIAL COVID-19 TREATMENTS

HITInfrastructure | March 26, 2020

news image

A drug discovery platform powered by artificial intelligence (AI) technology has identified 18 potential treatments for COVID-19, according to an annuncement from health IT company Gero. Six of the potential anti-COVID-19 drugs have already been approved, three have been withdrawn, and the other nine have already been tested in clinical trials for other indications. The COVID-19 outbreak and the legal and regulatory status of these drugs have made it possible to start various clinical tria...

Read More

HEALTH TECHNOLOGY

PYA AND GRASSI HEALTHCARE ADVISORS DEVELOP SUITE OF DATA-DRIVEN STRATEGIC SERVICES

PYA | December 07, 2020

news image

PYA and Grassi Healthcare Advisors (GHA) have dispatched Calibrated Performance™, an assistance line intended to help healthcare suppliers react to difficulties brought about by COVID-19 and other monetary stressors. While any supplier may profit by Calibrated Performance, given the pressing necessities of post-intense, gifted nursing (SNF), and senior consideration offices in the wake of the COVID-19 pandemic, PY...

Read More

HealthPayerIntelligence | February 07, 2020

news image

3 WAYS PAYERS DRIVE POPULATION HEALTH MANAGEMENT IN CANCER CARE

The industry’s transition into value-based care is characterized by a focus on data and patient centered care. By driving strong population health management, payers can excel in this value-based care model that relies on quality measures and patient outcomes to define successful care. Driving population health management is most needed but also particularly challenging for populations with complex, chronic diseases such as cancer. Cancer presents a population health challenge due to its m...

Read More

HITInfrastructure | February 27, 2020

news image

ONC ADDRESSES HEALTH IT INFRASTRUCTURE CHALLENGES IN NEW AGENDA

Innovative research and scientific breakthroughs may remain stagnant due to difficulties with health IT infrastructure and the lack of quality data, but ONC articulates ways to address these challenges in its new policy and development agenda. A new blog post written by the National Coordinator Don Rucker, MD, and ONC staffers Teresa Zayas Caban, Kevin Chaney, MGS, highlighted the efforts ONC is making to advance the nation’s health IT infrastructure to specifically achieve two goals...

Read More

HITInfrastructure | March 26, 2020

news image

AI DRUG DISCOVERY PLATFORM IDS POTENTIAL COVID-19 TREATMENTS

A drug discovery platform powered by artificial intelligence (AI) technology has identified 18 potential treatments for COVID-19, according to an annuncement from health IT company Gero. Six of the potential anti-COVID-19 drugs have already been approved, three have been withdrawn, and the other nine have already been tested in clinical trials for other indications. The COVID-19 outbreak and the legal and regulatory status of these drugs have made it possible to start various clinical tria...

Read More

HEALTH TECHNOLOGY

PYA | December 07, 2020

news image

PYA AND GRASSI HEALTHCARE ADVISORS DEVELOP SUITE OF DATA-DRIVEN STRATEGIC SERVICES

PYA and Grassi Healthcare Advisors (GHA) have dispatched Calibrated Performance™, an assistance line intended to help healthcare suppliers react to difficulties brought about by COVID-19 and other monetary stressors. While any supplier may profit by Calibrated Performance, given the pressing necessities of post-intense, gifted nursing (SNF), and senior consideration offices in the wake of the COVID-19 pandemic, PY...

Read More